Olshan Frome Wolosky represented TriStar Capital in the transaction. TriStar Capital and RAL Development executed the acquisition of $13 million worth of property needed to complete...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented Engaged Capital in the agreement. Engaged Capital and New Relic reached an agreement pursuant to which Radhakrishnan (RK) Mahendran was appointed to...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented 601W Companies in the transaction. 601W Companies executed the saled of 909 Third Avenue for $192.5 million to an entity led by...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Alzamend Neuro and Ault Global Holding, while Haynes & Boone LLP represented the underwriter in the offering. Alzamend Neuro, Inc. executed...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented IsZo Capital in the case. IsZo Capital filed a class action lawsuit against Emisphere Technologies Inc. seeking damages arising from a...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented the Korein Family in the transaction. The Korein Family executed the sale of 111 Wall Street for $220 million to a...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented Saba Capital Management in the transaction. Saba Capital Management, L.P. completed its proxy fight against Templeton Global Income Fund (NYSE: GIM). Shareholders...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented L.H. Charney Associates in the transaction. L.H. Charney Associates leased just over 67,000 s/f at 1410 Broadway and 10 Times Square...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented Summit Therapeutics in the offering. Summit Therapeutics Inc. (NASDAQ: SMMT) executed its rights offering of up to 14,312,977 shares of its...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Macellum Advisors GP, LLC, Ancora Holdings, Inc., Legion Partners Asset Management, LLC, and 4010 Capital, LLC and certain of the foregoing’s...
You must be a Standard 1 Year member to access this content.
